Combined therapy with daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b: a case report / 南方医科大学学报
Journal of Southern Medical University
;
(12): 1163-1164, 2016.
Artículo
en Chino
| WPRIM
| ID: wpr-286827
ABSTRACT
The combination therapy with daclatasvir and asunaprevir can achieve a high sustained viral response rate against hepatitis C virus (HCV) genotype 1, but so far this regimen has not been reported in the treatment of Chinese patients with chronic hepatitis C (CHC) genotype 1b. Here we report a case of CHC genotype 1b in a 44-year-old female chinese patient who was treated with this regimen for 24 weeks. The patient showed sustained viral response after the treatment and was clinically cured. During the treatment, the patient experienced a transient elevation of serum total bilirubin accompanied by lowered hemoglobin fluctuating between 100 and 110 g/L.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Antivirales
/
Sulfonamidas
/
Hepacivirus
/
Hepatitis C Crónica
/
Usos Terapéuticos
/
Quimioterapia
/
Genética
/
Genotipo
/
Imidazoles
/
Isoquinolinas
Límite:
Adulto
/
Femenino
/
Humanos
Idioma:
Chino
Revista:
Journal of Southern Medical University
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS